← Open Payments lookup

LAURIE LAVIN: Open Payments

NPI 1811435217 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,755 in 186 payments from 10 companies in 2025. Trend: 2023 $4,418 · 2024 $4,271 · 2025 $3,755

Food & beverage: $3,749Education: $5
CompanyPaymentsAmount
Alkermes, Inc.27$703
Otsuka America Pharmaceutical, Inc.39$629
Neurocrine BioSciences, Inc.23$523
Janssen Pharmaceuticals, Inc25$459
E.R. Squibb & Sons, L.L.C.22$383
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$372
ABBVIE INC.15$309
Teva Pharmaceuticals USA, Inc.13$239
Axsome Therapeutics, Inc.4$108
Corium, LLC1$30

Products named: ARISTADA, INGREZZA, COBENFY, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII.

Industry payments across NY — which companies pay providers there.